Sun Pharma Q2 results: Speciality business key to getting US business on track

Sun Pharma Q2 results: The drugmaker, which earns 37 per cent of its business from the US market, earned Rs 2,389.77 crore from the sale of formulations in the US in
Q2FY20 against Rs 2397 crore in the corresponding quarter of the
previous year

Read more: https://www.businesstoday.in/current/cor...

Actual news in your location


Similar news

Assam Bypolls: Campaigning ends 0 0 0
Using Art 370 for Maharashtra, Haryana polls \"unfortunate\": Congress 0 0 0
Using Art 370 for Maharashtra, Haryana polls \"unfortunate\": Congress 0 0 0
Assam Bypolls: Campaigning ends 0 0 0
Assam Bypolls: Campaigning ends 0 0 0
What was called temporary in Ambedkar's constitution lasted for 70 years: PM Modi 0 0 0
What was called temporary in Ambedkar's constitution lasted for 70 years: PM Modi 0 0 0
What was called temporary in Ambedkar's constitution lasted for 70 years: PM Modi 0 0 0
Explosion on Mumbai-Bengaluru highway, 1 dead 0 0 0
Explosion on Mumbai-Bengaluru highway, 1 dead 0 0 0